These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

792 related items for PubMed ID: 16737934

  • 1. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
    Ayello J, van de Ven C, Fortino W, Wade-Harris C, Satwani P, Baxi L, Simpson LL, Sanger W, Pickering D, Kurtzberg J, Cairo MS.
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
    [Abstract] [Full Text] [Related]

  • 2. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS.
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [Abstract] [Full Text] [Related]

  • 3. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J, Broxmeyer HE.
    Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743
    [Abstract] [Full Text] [Related]

  • 4. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M, Pievani A, Borleri G, Vago L, Fleischhauer K, Golay J, Introna M.
    Exp Hematol; 2009 May 15; 37(5):616-628.e2. PubMed ID: 19375652
    [Abstract] [Full Text] [Related]

  • 5. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ, Kuo ML.
    Cytotherapy; 2008 May 15; 10(4):397-405. PubMed ID: 18574772
    [Abstract] [Full Text] [Related]

  • 6. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG, Martinson J.
    Cytotherapy; 2004 May 15; 6(1):15-22. PubMed ID: 14985163
    [Abstract] [Full Text] [Related]

  • 7. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
    Tanaka J, Sugita J, Asanuma S, Arita K, Shono Y, Kikutchi M, Shiratori S, Wakasa K, Yasumoto A, Shigematu A, Kondo T, Kobayashi T, Asaka M, Imamura M.
    Hum Immunol; 2009 Sep 15; 70(9):701-5. PubMed ID: 19524005
    [Abstract] [Full Text] [Related]

  • 8. IL-2-activated cord blood mononuclear cells.
    Derzic S, Slone V, Sender L.
    Cytotherapy; 2005 Sep 15; 7(5):408-16. PubMed ID: 16236630
    [Abstract] [Full Text] [Related]

  • 9. Participation of the CD94 receptor complex in costimulation of human natural killer cells.
    Voss SD, Daley J, Ritz J, Robertson MJ.
    J Immunol; 1998 Feb 15; 160(4):1618-26. PubMed ID: 9469418
    [Abstract] [Full Text] [Related]

  • 10. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
    Lu PH, Negrin RS.
    J Immunol; 1994 Aug 15; 153(4):1687-96. PubMed ID: 7519209
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells.
    Fan YY, Yang BY, Wu CY.
    Immunol Invest; 2008 Aug 15; 37(1):79-96. PubMed ID: 18214801
    [Abstract] [Full Text] [Related]

  • 12. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 13. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
    Béziat V, Duffy D, Quoc SN, Le Garff-Tavernier M, Decocq J, Combadière B, Debré P, Vieillard V.
    J Immunol; 2011 Jun 15; 186(12):6753-61. PubMed ID: 21555534
    [Abstract] [Full Text] [Related]

  • 14. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M, Kjaergaard J, Kuppen PJ, Nannmark U, Agger R, Hokland P, Basse P.
    In Vivo; 1999 Jun 15; 13(3):199-204. PubMed ID: 10459491
    [Abstract] [Full Text] [Related]

  • 15. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M.
    Scand J Immunol; 2007 Feb 15; 65(2):126-38. PubMed ID: 17257217
    [Abstract] [Full Text] [Related]

  • 16. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F, Pardo N, Peiró M, Bertran E, Amill B, García J, Cubells J, Rueda F.
    Exp Hematol; 1995 Dec 15; 23(14):1445-52. PubMed ID: 8542930
    [Abstract] [Full Text] [Related]

  • 17. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L, Tuncer HH, Betancur M, Wolfberg A, Klingemann H.
    Biol Blood Marrow Transplant; 2008 Sep 15; 14(9):1031-1038. PubMed ID: 18721766
    [Abstract] [Full Text] [Related]

  • 18. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
    Tanaka J, Sugita J, Kato N, Toubai T, Ibata M, Shono Y, Ota S, Kondo T, Kobayashi T, Kobayashi M, Asaka M, Imamura M.
    Exp Hematol; 2007 Oct 15; 35(10):1562-6. PubMed ID: 17681668
    [Abstract] [Full Text] [Related]

  • 19. Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice.
    Harada H, Suzu S, Ito T, Okada S.
    Eur J Immunol; 2005 Dec 15; 35(12):3599-609. PubMed ID: 16304638
    [Abstract] [Full Text] [Related]

  • 20. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
    Koehl U, Esser R, Zimmermann S, Tonn T, Kotchetkov R, Bartling T, Sörensen J, Grüttner HP, Bader P, Seifried E, Martin H, Lang P, Passweg JR, Klingebiel T, Schwabe D.
    Klin Padiatr; 2005 Dec 15; 217(6):345-50. PubMed ID: 16307421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.